Gray Faculty of Medical & Health Sciences | Department of Emergency and Disaster Management | Tel Aviv University

Top menu
Main menu
Main Content

You are here

Gray Faculty of Medical & Health Sciences News

All topics

New Bioactive Ink for 3D Printing Combines Precision, Cell Adhesion, and Researchers at Tel Aviv University developed a bioactive 3D-printing ink that combines high printing precision with enhanced cell adhesion and antibacterial activity.

Gray Faculty Researchers Awarded US-Israel Binational Science Foundation (BSF) Researchers from the Gray Faculty of Medical and Health Sciences have been awarded research grants from the US-Israel Binational Science Foundation (BSF).

Dr. Tal Soffer Part of Horizon Europe-Funded BUILD-BONE Project Dr. Tal Soffer will lead the health and digital literacy work in a new Horizon Europe project focused on preventing osteoporosis among young people.

What Happens to Cells When We Stimulate Them with Electricity? A new conductive, self-healing hydrogel developed at Tel Aviv University could support wound healing through controlled electrical stimulation.

Hasan Ishtayeh Awarded Two-Year Postdoctoral Fellowship The fellowship will support Hasan Ishtayeh’s postdoctoral research at the University of Oxford.

Buwei Shao Awarded ISF Breakthrough Grant The grant will support a research visit to Prof. Nadav Ahituv’s lab at UCSF, advancing Shao’s research on hearing genomics and hereditary hearing loss.

First Graduating Class of the International Master's Program in Digital The first class of Tel Aviv University's International Master's Program in Digital Health celebrated the completion of their studies.

Prof. Anat Gafter-Gvili Appointed Head of the Gray School of Medicine

Prof. Anat Gafter-Gvili Appointed Head of the Gray School of Medicine Academic Appointment

Tal Bamberger Awarded Foulkes Foundation Fellowship AI and the Microbiome: Shaping the Future of Medicine

Noam Rattner Awarded Prestigious Foulkes Foundation Fellowship Noam Rattner, a student in the combined D.M.D.-Ph.D. program at the Goldschleger School of Dental Medicine, has been awarded the prestigious Foulkes Foundation Fellowship, recognizing outstanding students in clinician-scientist training programs.

Experimental Treatment May Slow Fatal Brain Disease in Women A new study from Tel Aviv University suggests that the experimental drug Davunetide significantly slowed the progression of progressive supranuclear palsy (PSP) in women, highlighting the importance of sex-specific approaches to treating neurodegenerative diseases.

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained

here and / or the use of such content is in your opinion infringing Contact us as soon as possible >>

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel